In addition to these skin tumor models, xenograft assays with nude mice injected with K17 shRNA expressing A673 or SK-N-MC Ewing Sarcoma cells [52] and SiHa and CaSki cervical cancer cells [53] also revealed K17 to be critical for aggressive tumor growth in vivo (Table 1). This evidence concerns the gene KRT17 and cervical carcinoma.